LifeMD Inc Preferred Series A

$ 23.48

0.21%

31 Jul - close price

  • Market Cap N/A
  • Current Price $ 23.48
  • High / Low $ 23.50 / 23.42
  • Stock P/E N/A
  • Book Value 0.32
  • EPS -2.26
  • Next Earning Report -
  • Dividend Per Share N/A
  • Dividend Yield 0 %
  • Next Dividend Date -
  • ROA -0.13 %
  • ROE -2.38 %
  • 52 Week High 23.63
  • 52 Week Low 17.22

About

LifeMD, Inc. is a direct-to-patient telehealth company that connects consumers with healthcare professionals for care in a variety of indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company is headquartered in New York, New York.

Analyst Target Price

N/A

Quarterly Earnings

Sep 2025Jun 2025Mar 2025Dec 2024Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019
Reported Date 2025-11-172025-08-052025-05-062025-03-102021-08-132021-05-142021-03-302020-11-162020-08-142020-05-192020-03-302019-11-14
Reported EPS -0.1-0.060.01-0.02-0.54-0.6402-0.4742-2.5677-1.65-0.3655-0.23-0.071
Estimated EPS 000000000000
Surprise -0.1-0.060.01-0.02-0.54-0.6402-0.4742-2.5677-1.65-0.3655-0.23-0.071
Surprise Percentage None%None%None%None%None%None%None%None%None%None%None%None%

Next Quarterly Earnings

Reported Date
Fiscal Date Ending
Estimated EPS
Currency

Previous Dividend Records

Jul 2026Apr 2026Jan 2026Oct 2025Jan 1970Apr 2025Jan 2025Oct 2024Jul 2024Apr 2024
Payment Date 2026-07-152026-04-152026-01-152025-10-15None2025-04-152025-01-152024-10-152024-07-152024-04-15
Amount $0.5546875$0.5546875$0.5546875$0.5546875$0.5546875$0.5546875$0.5546875$0.5546875$0.5546875$0.5546875

Next Dividend Records

Dividend per share (year): -
Dividend Yield -
Next Dividend Date -
Ex-Dividend Date -

Recent News: LFMDP

...
LifeMD Inc (LFMD) Technical Analysis: Support, Resistance, Indicators & Moving Averages

2026-07-30 13:39:31

This article provides a technical analysis of LifeMD Inc (LFMD), detailing its current price momentum score, support and resistance levels, and indicator readings. It shows that LFMD has a price momentum score of 4.85, is trading between a resistance of $4.52 and support of $2.96, and has a mix of "Sell" and "Neutral" signals from various technical indicators and moving averages. The analysis suggests the stock is suitable for range-bound swing trading, with FAQs explaining technical ratings and moving averages.

LifeMD to report Q2 2026 results after market close, host conference call

2026-07-25 00:09:50

LifeMD announced it will release its second-quarter 2026 financial results on August 5, 2026, after the U.S. market closes. The company will also host a conference call on the same day at 4:30 p.m. ET to discuss the results, with webcast access available. This news brief was generated by Public Technologies using AI.

...
FEDERATED HERMES, INC. Acquires Significant Stake in LifeMD Inc

2026-07-15 01:15:32

FEDERATED HERMES, INC. has acquired 1,728,578 shares of LifeMD Inc, increasing its total holdings to 2,747,655 shares, which represents a 5.68% stake in the telehealth company. This strategic investment highlights the firm's confidence in the telehealth sector's growth potential and LifeMD Inc's business model. LifeMD Inc is considered modestly undervalued with a GF Score of 76/100 and has shown notable EBITDA growth, making it a potential opportunity for value investors.

B. Riley Securities Initiates LifeMD(LFMD.US) With Buy Rating, Announces Target Price $10

2026-06-29 15:11:44

B. Riley Securities has initiated coverage on LifeMD (LFMD.US) with a Buy rating and set a target price of $10. This signals a positive outlook from the investment firm regarding the company's future stock performance.

...
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

2026-06-23 23:39:54

LifeMD, Inc. announced a cash dividend of $0.5546875 per share for its 8.875% Series A Cumulative Perpetual Preferred Stock. The dividend will be paid on July 15, 2026, to shareholders of record as of July 3, 2026. LifeMD is a telehealth company providing virtual primary care and specialized treatments leveraging a digital care platform and affiliated medical and pharmacy services.

...
LifeMD Appoints Umesh Sripad as Chief Technology Officer

2026-06-01 08:05:00

LifeMD, Inc. (Nasdaq: LFMD) has appointed Umesh Sripad as its new Chief Technology Officer, effective immediately. Sripad, who has over two decades of experience in digital transformation, will oversee LifeMD's technology strategy, AI enablement, and platform scalability as the company expands its virtual primary care services. This strategic hire aims to support LifeMD's growth from serving 350,000 patients to potentially millions, leveraging Sripad's expertise from previous roles at PetMeds, PureRED, Bed Bath & Beyond, and IKEA USA.

Iscriviti alla nostra newsletter

Email Subscription Form


Resta aggiornato. Ricevi tutti i nuovi articoli e le notizie ogni settimana.
banner startinvesting

Questo si chiuderà in 0 secondi